Cargando…
Hypoxia in Lung Cancer Management: A Translational Approach
SIMPLE SUMMARY: Hypoxia is a common feature of lung cancers. Nonetheless, no guidelines have been established to integrate hypoxia-associated biomarkers in patient management. Here, we discuss the current knowledge and provide translational novel considerations regarding its clinical detection and t...
Autores principales: | Ancel, Julien, Perotin, Jeanne-Marie, Dewolf, Maxime, Launois, Claire, Mulette, Pauline, Nawrocki-Raby, Béatrice, Dalstein, Véronique, Gilles, Christine, Deslée, Gaëtan, Polette, Myriam, Dormoy, Valérian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307602/ https://www.ncbi.nlm.nih.gov/pubmed/34298636 http://dx.doi.org/10.3390/cancers13143421 |
Ejemplares similares
-
Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors
por: Ancel, Julien, et al.
Publicado: (2023) -
Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD
por: Ancel, Julien, et al.
Publicado: (2021) -
Bronchoscopic management of asthma, COPD and emphysema
por: Perotin, Jeanne Marie, et al.
Publicado: (2021) -
Programmed Death–Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC
por: Ancel, Julien, et al.
Publicado: (2019) -
Nicotinic Receptor Subunits Atlas in the Adult Human Lung
por: Diabasana, Zania, et al.
Publicado: (2020)